• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

致癌蛋白CIC::DUX4通过直接调控DNA聚合酶ε(POLE)的催化亚基来维持DNA完整性。

The CIC::DUX4 oncoprotein maintains DNA integrity through direct regulation of the catalytic subunit of DNA polymerase epsilon (POLE).

作者信息

Kosibaty Zeinab, Luck Cuyler, Okimoto Ross A

机构信息

Department of Medicine, University of California, San Francisco, CA, USA.

Helen Diller Comprehensive Cancer Center, University of California, San Francisco, CA, USA.

出版信息

Oncogene. 2025 Aug 4. doi: 10.1038/s41388-025-03507-9.

DOI:10.1038/s41388-025-03507-9
PMID:40760094
Abstract

Transcription factor (TF) fusion oncoproteins represent cancer-specific alterations that arise from chromosomal rearrangements. Through target gene recognition, TF fusions can disseminate transcriptional responses that collectively work to drive tumorigenesis. Thus, identifying the molecular targets that operate as a disease-driving network can potentially uncover key actionable dependencies. We have taken this strategy to dissect the underlying biological mechanism by which CIC::DUX4, a fusion oncoprotein associated with dismal outcomes, drives sarcomagenesis. We and others have defined a CIC::DUX4 fusion-mediated network that dysregulates cell-cycle and DNA replication checkpoints. Specifically, CIC::DUX4-mediated CCNE1 upregulation compromises the G1/S transition, leading to high DNA replication stress and conferring a dependence on the G2/M checkpoint kinase, WEE1. WEE1 provides a molecular brake to enable effective DNA repair prior to mitotic entry. Importantly, the mechanism by which CIC::DUX4 regulates DNA repair remains unknown. Here we show that the catalytic subunit of DNA polymerase epsilon (POLE) is essential for DNA integrity and cellular division in CIC::DUX4 sarcoma. Mechanistically, POLE loss increases DNA damage and induces p21-mediated cellular senescence to limit CIC::DUX4 tumor growth in vitro and tumor formation in vivo. Collectively, we credential POLE as a CIC::DUX4 target and further characterize a functional network through which CIC::DUX4 operates to drive tumor progression and survival.

摘要

转录因子(TF)融合癌蛋白代表了由染色体重排产生的癌症特异性改变。通过靶基因识别,TF融合可以传播转录反应,这些反应共同作用以驱动肿瘤发生。因此,识别作为疾病驱动网络发挥作用的分子靶点可能会揭示关键的可操作依赖性。我们采用了这种策略来剖析与不良预后相关的融合癌蛋白CIC::DUX4驱动肉瘤发生的潜在生物学机制。我们和其他人已经定义了一个CIC::DUX4融合介导的网络,该网络失调细胞周期和DNA复制检查点。具体而言,CIC::DUX4介导的CCNE1上调损害G1/S期转换,导致高DNA复制应激,并赋予对G2/M检查点激酶WEE1的依赖性。WEE1提供一个分子刹车,以便在有丝分裂进入之前进行有效的DNA修复。重要的是,CIC::DUX4调节DNA修复的机制仍然未知。在这里,我们表明DNA聚合酶ε(POLE)的催化亚基对于CIC::DUX4肉瘤中的DNA完整性和细胞分裂至关重要。从机制上讲,POLE缺失会增加DNA损伤并诱导p21介导的细胞衰老,以限制CIC::DUX4在体外的肿瘤生长和体内的肿瘤形成。总的来说,我们证实POLE是CIC::DUX4的一个靶点,并进一步表征了一个功能网络,通过该网络CIC::DUX4发挥作用以驱动肿瘤进展和存活。

相似文献

1
The CIC::DUX4 oncoprotein maintains DNA integrity through direct regulation of the catalytic subunit of DNA polymerase epsilon (POLE).致癌蛋白CIC::DUX4通过直接调控DNA聚合酶ε(POLE)的催化亚基来维持DNA完整性。
Oncogene. 2025 Aug 4. doi: 10.1038/s41388-025-03507-9.
2
WEE1 kinase is a therapeutic vulnerability in CIC-DUX4 undifferentiated sarcoma.WEE1 激酶是 CIC-DUX4 未分化肉瘤的治疗靶点。
JCI Insight. 2022 Mar 22;7(6):e152293. doi: 10.1172/jci.insight.152293.
3
Short-Term Memory Impairment短期记忆障碍
4
CIC::DUX4 Sarcoma With Preferentially Expressed Antigen in Melanoma (PRAME) Immunopositivity.伴有黑色素瘤优先表达抗原(PRAME)免疫阳性的CIC::DUX4肉瘤
Cureus. 2025 May 31;17(5):e85154. doi: 10.7759/cureus.85154. eCollection 2025 May.
5
Can a Liquid Biopsy Detect Circulating Tumor DNA With Low-passage Whole-genome Sequencing in Patients With a Sarcoma? A Pilot Evaluation.液体活检能否通过低深度全基因组测序检测肉瘤患者的循环肿瘤DNA?一项初步评估。
Clin Orthop Relat Res. 2025 Jan 1;483(1):39-48. doi: 10.1097/CORR.0000000000003161. Epub 2024 Jun 21.
6
CIC/ATXN1-rearranged tumors in the central nervous system are mainly represented by sarcomas: A comprehensive clinicopathological and epigenetic series.中枢神经系统中CIC/ATXN1重排的肿瘤主要为肉瘤:一项全面的临床病理和表观遗传学研究系列。
Brain Pathol. 2025 Mar;35(2):e13303. doi: 10.1111/bpa.13303. Epub 2024 Oct 23.
7
The Extensive Case Series of 21 CIC::DUX4 , 18 BCOR::CCNB3 and 148 Ewing's Sarcomas From a Single Center.来自单一中心的21例CIC::DUX4、18例BCOR::CCNB3和148例尤因肉瘤的广泛病例系列。
Am J Surg Pathol. 2025 Apr 29;49(8):837-853. doi: 10.1097/PAS.0000000000002403.
8
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
9
Molecular feature-based classification of retroperitoneal liposarcoma: a prospective cohort study.基于分子特征的腹膜后脂肪肉瘤分类:一项前瞻性队列研究。
Elife. 2025 May 23;14:RP100887. doi: 10.7554/eLife.100887.
10
-Rearranged Sarcoma: A Clinical and Pathological Study of a Peculiar Entity.- 重排肉瘤:一种特殊实体的临床与病理研究
Diagnostics (Basel). 2025 Jul 11;15(14):1758. doi: 10.3390/diagnostics15141758.

本文引用的文献

1
Molecular and therapeutic advancements in Capicua ()-rearranged sarcoma.Capicua()重排肉瘤的分子与治疗进展
Front Cell Dev Biol. 2024 May 31;12:1416697. doi: 10.3389/fcell.2024.1416697. eCollection 2024.
2
Proteomic Characterization of Undifferentiated Small Round Cell Sarcomas With EWSR1 and CIC::DUX4 Translocations Reveals Diverging Tumor Biology and Distinct Diagnostic Markers.EWSR1 和 CIC::DUX4 易位的未分化小圆细胞肉瘤的蛋白质组学特征揭示了不同的肿瘤生物学和独特的诊断标志物。
Mod Pathol. 2024 Jul;37(7):100511. doi: 10.1016/j.modpat.2024.100511. Epub 2024 May 3.
3
Differential cyclin-E1 expression in CIC-rearranged sarcoma.
CIC 重排肉瘤中细胞周期蛋白 E1 的差异表达。
Ann Diagn Pathol. 2024 Oct;72:152320. doi: 10.1016/j.anndiagpath.2024.152320. Epub 2024 Apr 27.
4
Senescence and cancer - role and therapeutic opportunities.衰老与癌症——作用与治疗机遇。
Nat Rev Clin Oncol. 2022 Oct;19(10):619-636. doi: 10.1038/s41571-022-00668-4. Epub 2022 Aug 31.
5
Hyperactive CDK2 Activity in Basal-like Breast Cancer Imposes a Genome Integrity Liability that Can Be Exploited by Targeting DNA Polymerase ε.基底样乳腺癌中 CDK2 的过度激活导致基因组完整性缺陷,可通过靶向 DNA 聚合酶 ε 加以利用。
Mol Cell. 2020 Nov 19;80(4):682-698.e7. doi: 10.1016/j.molcel.2020.10.016. Epub 2020 Nov 4.
6
CIC-DUX4 oncoprotein drives sarcoma metastasis and tumorigenesis via distinct regulatory programs.CIC-DUX4 癌蛋白通过不同的调控程序驱动肉瘤转移和肿瘤发生。
J Clin Invest. 2019 Jul 22;129(8):3401-3406. doi: 10.1172/JCI126366.
7
EWS/FLI Confers Tumor Cell Synthetic Lethality to CDK12 Inhibition in Ewing Sarcoma.EWS/FLI 使 CDK12 抑制在尤文肉瘤中具有肿瘤细胞合成致死性。
Cancer Cell. 2018 Feb 12;33(2):202-216.e6. doi: 10.1016/j.ccell.2017.12.009. Epub 2018 Jan 18.
8
Generation of novel patient-derived CIC- DUX4 sarcoma xenografts and cell lines.新型患者来源的 CIC-DUX4 肉瘤异种移植瘤和细胞系的构建。
Sci Rep. 2017 Jul 5;7(1):4712. doi: 10.1038/s41598-017-04967-0.
9
Sarcomas With CIC-rearrangements Are a Distinct Pathologic Entity With Aggressive Outcome: A Clinicopathologic and Molecular Study of 115 Cases.伴有CIC重排的肉瘤是一种具有侵袭性预后的独特病理实体:115例病例的临床病理和分子研究
Am J Surg Pathol. 2017 Jul;41(7):941-949. doi: 10.1097/PAS.0000000000000846.
10
Targeting WEE1 Kinase in Cancer.靶向癌症中的 WEE1 激酶。
Trends Pharmacol Sci. 2016 Oct;37(10):872-881. doi: 10.1016/j.tips.2016.06.006. Epub 2016 Jul 14.